| |
Video - demo.
|
|
|
 |
| Journal on focus |
|
Editor-in-Chief
M.V. Blagosklonny, M.D., Ph.D.
Ordway Research Institute
Cancer Center
Albany, NY |
 |
| Gallery |
 |
| |
|
|

 |
 |
FOCUS |
 |
 |
| |
 |
|
 |
Anti-aging drug today
Therapy of age-related diseases by slowing aging based on novel
use of rapamycin, its combinations and formulations. |
 |
Toxicity-free cancer therapy
therapy of cancer without side effects by drug combinations that selectively kill cancer cells, while sparing normal cells, based on drug resistance and cell cycle. |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
LATEST NEWS |
 |
 |
 |
| |
Feb. 29, 2008 - Announcement: Oncotarget Inc. is looking for collaborations in the area of anti-cancer drugs with defined targets. |
 |
Sept. 1, 2007 - On September 1, 2007 Oncotarget Inc. was awarded Phase I of STTR - NIH grant "Drug discovery for diabetic retinopathy." |
 |
|
 |
|
|
 |
 |
 |
 |
 |
 |
|
|
 |